Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of VDR-Responsive Gene Signatures in Breast Cancer Cells

1 Jan 2006

Abstract excerpt

<i>Objectives:</i> Defining transcriptional profiles which predict cancer cell anti-proliferative responsiveness towards 1,25-dihydroxyvitamin D<sub>3</sub> [1α,25(OH)<sub>2</sub>D<sub>3</sub>] is required to improve and tailor the chemotherapeutic application of this seco-steroid hormone to individual cancer patients. <i>Methods:</i> We undertook a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen and related hormone effects
Share to Growth Hormone and Insulin-like Growth Factors
Share to Vitamin D Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17377416
DOI: 10.1159/000100989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of VDR-Responsive Gene Signatures in Breast Cancer CellsPMID 17377416Read ↗

Gene Signatures of 1,25‐Dihydroxyvitamin D<sub>3</sub> Exposure in Normal and Transformed Mammary CellsSemantic proximity Read ↗

Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer ChemoresistanceSemantic proximity Read ↗

Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to LetrozoleSemantic proximity Read ↗

Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)Semantic proximity Read ↗

Endocrine Resistance Score Based on Three Key Genes Predicts Prognosis and Reveals Potential Therapeutic Targets for ER + HER2 − Breast CancerSemantic proximity Read ↗

The impact of vitamin D in breast cancer: genomics, pathways, metabolismSemantic proximity Read ↗

Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies.Semantic proximity Read ↗

Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cellsSemantic proximity Read ↗

PML1-Mediated Feedforward Loop Through PI3K and MAPK Axes Drives Endocrine ResistanceSemantic proximity Read ↗

Endocrine therapy-specific lineage and partial epithelial-mesenchymal reprogramming defines divergent resistant cell-states in ER+ breast cancerSemantic proximity Read ↗

A Novel Group of Genes that Causes Endocrine Resistance in Breast Cancer Identified by Dynamic Gene Expression AnalysisSemantic proximity Read ↗

Endocrine resistance in breast cancer--An overview and update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.